SCHEMBL7959569

SCHEMBL7959569

COC(=O)N1C2C=CC1CC2

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
GRM5 P41594 11/20 0.36
CHRNB2 P17787 2/20 0.35
CHRNA4 P43681 2/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
ABCB1 P08183 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
LPO P22079 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12276755 0.81 CHRM2 (0.37) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL12277339 0.81 CHRM2 (0.37) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL12274835 0.81 CHRM2 (0.37) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL12275534 0.81 CHRM2 (0.37) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL12319985 0.81 CHRM2 (0.37) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL12320731 0.81 TSHR (0.41) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL551926 0.79 MEN1 (0.37) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL15854063 0.79 MEN1 (0.37) TSHRGRM5CHRNB2CHRNA4CHRNB4
SCHEMBL1721478 0.77 CHRM2 (0.53) SMN1; SMN2KDM4EMAPT
SCHEMBL10970531 0.73 TSHR (0.40) TSHRCHRNB2CHRNA4CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6255490-B1 TREATING DISORDERS ASSOCIATED WITH CHANGES IN CHOLINERGIC ACTIVITY; NON-OPIATE BASED ANALGESIC FOR MODERATE TO SEVERE PAIN EQUALLY OR EXCEEDING THE POTENCY OF OPIATE ANALGESICS, YET LACKING ADDICTIVE SIDE EFFECTS UNIVERSITY OF VIRGINIA 2001-07-03 US disclosed
US-6060473-A 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands UCB S.A. - DTB (BE) 2000-05-09 US disclosed
EP-0778835-A4 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIV VIRGINIA (US) 1999-02-03 EP disclosed
EP-0778835-A1 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIVERSITY OF VIRGINIA (US) 1997-06-18 EP disclosed
WO-1996006093-A1 7-AZABICYCLO[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIVERSITY OF VIRGINIA (US) 1996-02-29 WO disclosed